Air Purifier Use and Respiratory Health in COPD Patients
ConditionRespiratory Health
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age50-80
SponsorFudan University
About this trial
This randomized, double-blind, parallel-controlled trial aims to evaluate the effects of an indoor air purifier intervention on respiratory health in patients with Chronic Obstructive Pulmonary Disease (COPD).
Eligibility criteria
Qualifiers
Age between 50 and 80 years old
Physician diagnosis of COPD
Living in Shanghai during the intervention period
Subjects who have no plans to change homes during the intervention period
Disqualifiers
Subjects living in a location other than home
Subjects with a history of alcohol abuse
Subjects with other chronic lung diseases, such as active tuberculosis, pulmonary fibrosis, cystic fibrosis, or alpha-1 antitrypsin deficiency
Subjects with a history of thoracic surgery
Trial design
Treatments tested in this trial
- Using air purifiers with high-efficiency particulate air (HEPA) and carbon filters
- Using air purifiers with non-functional filtration system
Treatment groups
120 Participants
are divided into 2 treatment groupsSponsors and collaborators
Source ClinicalTrials.gov